Literature DB >> 8632645

A population of cells isolated from rat heart capable of differentiating into several mesodermal phenotypes.

D J Warejcka1, R Harvey, B J Taylor, H E Young, P A Lucas.   

Abstract

A population of stem cells has been isolated from embryonic avian and neonatal rat skeletal muscle. These cells differentiate into several mesodermal phenotypes in culture upon treatment with dexamethasone. This study reports the isolation of a similar population of stem cells from another mesodermal tissue, the heart. Hearts were excised from 3- to 5-day- old rats, minced, and treated with a collagenase-dispase solution. Single cells were collected by centrifugation, washed, and plated in dishes. The cells were grown to confluence, trypsinized, and frozen at -80 degrees C in 7.5% dimethylsulfoxide. After at least 24 hr, the cells were thawed and plated in 24-well plates and treated with media containing dexamethasone at concentrations of 10(-6)-10(-10) M for 4 weeks. Control cultures contained mononucleated cells with a stellate morphology. Treatment with dexamethasone resulted in the appearance of several mesodermal phenotypes. Bone and cartilage nodules were identified with von Kossa and Alcian blue staining respectively. Adipocytes were identified using Sudan black B stain. Smooth muscle cells were identified by an anti-smooth muscle alpha-actin antibody, and skeletal myotubes were stained with anti-myosin antibody. Large binuclear cells with obvious fibers were noted and stained with anti-desmin. These binuclear cells appeared in both the control and the dexamethasone-treated cultures and were tentatively identified as cardiomyocytes. These data strongly suggest the existence of a population of mesenchymal stem cells in neonatal rat heart.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632645     DOI: 10.1006/jsre.1996.0201

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Authors:  Igor B Resnick; Claudine Barkats; Michael Y Shapira; Polina Stepensky; Allan I Bloom; Avichai Shimoni; David Mankuta; Nira Varda-Bloom; Lyudmila Rheingold; Moshe Yeshurun; Bella Bielorai; Amos Toren; Tsila Zuckerman; Arnon Nagler; Reuven Or
Journal:  Am J Blood Res       Date:  2013-08-19

2.  Osteosarcoma cells differentiate into phenotypes from all three dermal layers.

Authors:  Scott Russinoff; Sara Miran; Ashok L Gowda; Paul A Lucas
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

Review 3.  Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis.

Authors:  Mariana Valente; Diana Santos Nascimento; Ana Cumano; Perpétua Pinto-do-Ó
Journal:  Stem Cells Dev       Date:  2014-07-14       Impact factor: 3.272

Review 4.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

5.  Identification of tissue-specific vasculogenic cells originating from murine uterus.

Authors:  Narumi Onodera; Tetsuro Tamaki; Yoshinori Okada; Akira Akatsuka; Daisuke Aoki
Journal:  Histochem Cell Biol       Date:  2005-11-26       Impact factor: 4.304

6.  Muscle-derived Gr1(dim)CD11b(+) cells enhance neovascularization in an ischemic hind limb mouse model.

Authors:  Jeong A Kim; Keith March; Hee-Don Chae; Brian Johnstone; Su-Jung Park; Todd Cook; Stephanie Merfeld-Clauss; Hal E Broxmeyer
Journal:  Blood       Date:  2010-06-01       Impact factor: 22.113

Review 7.  Changing Paradigms in Cranio-Facial Regeneration: Current and New Strategies for the Activation of Endogenous Stem Cells.

Authors:  Luigi Mele; Pietro Paolo Vitiello; Virginia Tirino; Francesca Paino; Alfredo De Rosa; Davide Liccardo; Gianpaolo Papaccio; Vincenzo Desiderio
Journal:  Front Physiol       Date:  2016-02-24       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.